Influenza Vaccine 2020-2021 Update – A New Vaccine Option for Patients


1 hour



# of Credits




Expiry Date


Each year influenza is responsible for an average 12,200 hospitalizations and 3500 deaths in Canada. Influenza immunization is the most effective method of preventing influenza and its complications. With the circulation of COVID-19, there is increasing concern of two potential highly infectious diseases circulating in Canada simultaneously. The National Advisory Committee on Immunization (NACI) has updated their recommendations for the 2020-2021 season. This program will review the new recommendations, introduce the new cell-based influenza vaccine, and discuss the importance and strategies to protect the priority group of older adults.

This Self-Learning program has been certified by the College of Family Physicians of Canada for up to 1 Mainpro+ credits.​ Cert+ Program ID#: 193258


Anas Nseir, MD, CCFP, FCFP, B. Pharm

Chandi Chandrasena, MD, CCFP, FCFP

John Axler, MD, CCFP, FCFP

Mark Loeb, MD, FRCPC, MSc

Upon completion of this continuing education program participants will be better able to:

  • Review the key recommendations from the 2020-2021 NACI statement on influenza immunization
  • Determine the potential role of cell-based influenza vaccines
  • Describe important factors to consider with influenza immunization in older adults
  • Review the different vaccine options for older adults
  • Recognize the potential impact of COVID-19 on influenza immunization

Related Courses